Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Schuurhuis, G.J."'
Autor:
Chamuleau, M.E.D., Ossenkoppele, G.J., van Rhenen, A., van Dreunen, L., Jirka, S.M.G., Zevenbergen, A., Schuurhuis, G.J., van de Loosdrecht, A.A.
Publikováno v:
In Leukemia Research June 2011 35(6):741-749
Autor:
Braakman, E., Schuurhuis, G.J., Preijers, F.W.M.B., Voermans, C., Theunissen, K., van Riet, I., Fibbe, W.E., Slaper-Cortenbach, I.
Publikováno v:
In Cytotherapy 2008 10(1):83-89
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Schuurhuis, G J, Zeijlemaker, W & Cloos, J 2015, Flow cytometric MRD and leukemia stem cell frequency assessment to develop risk-stratified approaches in AML . in Annals of Hematology . Annals of Hematology, vol. 94, Springer Verlag, G.J. Schuurhuis, Department of Hematology, Amsterdam, Netherlands, pp. S49-S51 . < http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71868790 >
Annals of Hematology, S49-S51
STARTPAGE=S49;ENDPAGE=S51;TITLE=Annals of Hematology
Annals of Hematology, S49-S51
STARTPAGE=S49;ENDPAGE=S51;TITLE=Annals of Hematology
Minimal residual disease (MRD) has been found to offer an independent post-remission prognostic marker in acute myeloid leukaemia (AML). We have confirmed this in a large blinded study in which MRD was assessed in parallel to a HOVON therapy protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0b0d802ecd62315fd4681dfd0c3cf9c2
https://research.vumc.nl/en/publications/b94d6d9d-c1f9-4634-8b43-57e02b5c171f
https://research.vumc.nl/en/publications/b94d6d9d-c1f9-4634-8b43-57e02b5c171f
Publikováno v:
Cytometry Part B. Clinical Cytometry, 86(1), 3-14. Wiley-Liss Inc.
Zeijlemaker, W, Gratama, J W & Schuurhuis, G J 2014, ' Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease ', Cytometry Part B. Clinical Cytometry, vol. 86, no. 1, pp. 3-14 . https://doi.org/10.1002/cyto.b.21134
Zeijlemaker, W, Gratama, J W & Schuurhuis, G J 2014, ' Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease ', Cytometry Part B. Clinical Cytometry, vol. 86, no. 1, pp. 3-14 . https://doi.org/10.1002/cyto.b.21134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1dfdd4e6f19deb03e45f668104250adf
https://research.vumc.nl/en/publications/3d22a3f7-3e2b-46c9-88d9-ab5d6a5c8ef5
https://research.vumc.nl/en/publications/3d22a3f7-3e2b-46c9-88d9-ab5d6a5c8ef5
Autor:
Martens-de Kemp, S.R., Brink, Arjen, Stigter-van Walsum, M., Damen, J.M.A., Rustenburg, F., Wu, T., van Wieringen, W.N., Schuurhuis, G.J., Braakhuis, B.J.M., Slijper, M., Brakenhoff, R.H., Biomolecular Mass Spectrometry and Proteomics, Sub Biomol.Mass Spect. and Proteomics
Publikováno v:
Stem Cell Research, 10(3), 477. Elsevier
de Kemp, S R, Brink, A, Stigter-van Walsum, M, Damen, J M A, Rustenburg, F, Wu, T, van Wieringen, W N, Schuurhuis, G J, Braakhuis, B J M, Slijper, M & Brakenhoff, R H 2013, ' CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties ', Stem Cell Research, vol. 10, no. 3, pp. 477-488 . https://doi.org/10.1016/j.scr.2013.02.004
Stem Cell Research, 10(3), 477-488. Elsevier
de Kemp, S R, Brink, A, Stigter-van Walsum, M, Damen, J M A, Rustenburg, F, Wu, T, van Wieringen, W N, Schuurhuis, G J, Braakhuis, B J M, Slijper, M & Brakenhoff, R H 2013, ' CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties ', Stem Cell Research, vol. 10, no. 3, pp. 477-488 . https://doi.org/10.1016/j.scr.2013.02.004
Stem Cell Research, 10(3), 477-488. Elsevier
Patients with advanced head and neck squamous cell carcinomas (HNSCCs) are often treated with concomitant chemotherapy and radiotherapy, but only 50% is cured. A possible explanation for treatment failure is therapy resistance of the cancer stem cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34fba5a51fe1ee152aa01f04e31d6e87
https://dspace.library.uu.nl/handle/1874/290834
https://dspace.library.uu.nl/handle/1874/290834
Publikováno v:
Translational Pediatrics, 2(2), 80-83. AME Publishing Company
Schuurhuis, G J, Cloos, J & Ossenkoppele, G J 2013, ' How to assess minimal residual disease in pediatric and adult acute myeloid leukemia? ', Translational Pediatrics, vol. 2, no. 2, pp. 80-83 . https://doi.org/10.3978/j.issn.2224-4336.2013.04.09
Schuurhuis, G J, Cloos, J & Ossenkoppele, G J 2013, ' How to assess minimal residual disease in pediatric and adult acute myeloid leukemia? ', Translational Pediatrics, vol. 2, no. 2, pp. 80-83 . https://doi.org/10.3978/j.issn.2224-4336.2013.04.09
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5c9c1ad16b5975ab712c61f2f4c4a188
https://research.vumc.nl/en/publications/9f7a3a48-1916-4754-8db7-3242d4586243
https://research.vumc.nl/en/publications/9f7a3a48-1916-4754-8db7-3242d4586243
Autor:
Buccisano, F., Maurillo, L., Schuurhuis, G.J., Del Principe, M.I., Di Veroli, A., Gurnari, C., Venditti, A.
Publikováno v:
Seminars in Hematology; April 2019, Vol. 56 Issue: 2 p125-130, 6p
Autor:
Terwijn, M., Kelder, A., Snel, A.N., Rutten, A.P., Scholten, W.J., Oussoren, Y.J.M., van de Loosdrecht, A.A., Zweegman, S., Ossenkoppele, G.J., Schuurhuis, G.J.
Publikováno v:
International journal of laboratory hematology, 34(4), 432-441. Wiley-Blackwell
Terwijn, M, Kelder, A, Snel, A N, Rutten, A P, Scholten, W J, Oussoren, Y J M, van de Loosdrecht, A A, Zweegman, S, Ossenkoppele, G J & Schuurhuis, G J 2012, ' Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia ', International journal of laboratory hematology, vol. 34, no. 4, pp. 432-441 . https://doi.org/10.1111/j.1751-553X.2012.01416.x
Terwijn, M, Kelder, A, Snel, A N, Rutten, A P, Scholten, W J, Oussoren, Y J M, van de Loosdrecht, A A, Zweegman, S, Ossenkoppele, G J & Schuurhuis, G J 2012, ' Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemia ', International journal of laboratory hematology, vol. 34, no. 4, pp. 432-441 . https://doi.org/10.1111/j.1751-553X.2012.01416.x
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5f41b73e0debd4be7189671fe4edf613
https://research.vumc.nl/en/publications/c1568714-72f7-484b-863d-58b5ad1cbf8c
https://research.vumc.nl/en/publications/c1568714-72f7-484b-863d-58b5ad1cbf8c
Publikováno v:
Thielen, N, Ossenkoppele, G J, Schuurhuis, G J & Janssen, J J W M 2011, ' New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure ', Netherlands Journal of Medicine, vol. 69, no. 10, pp. 430-440 . < http://www.njmonline.nl/getpdf.php?t=a&id=10000767 >
Netherlands Journal of Medicine, 69(10), 430-440. Van Zuiden Communications BV
Netherlands Journal of Medicine, 69(10), 430-440. Van Zuiden Communications BV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::792abb646178ddcdbc55ce3f1a717640
https://research.vumc.nl/en/publications/5413a70e-0c0f-4bc6-b9d4-0d3d412f39f9
https://research.vumc.nl/en/publications/5413a70e-0c0f-4bc6-b9d4-0d3d412f39f9